Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EBIRIOS - Exenatide and Basal Insulins Use in the Real Setting: an Italian Observational Study in Patients With Type 2 Diabetes and Secondary Failure of Oral Antihyperglycemic Treatment

NCT01060059 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01060059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01060059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EBIRIOS - Exenatide and Basal Insulins Use in the Real Setting: an Italian Observational Study in Patients With Type 2 Diabetes and Secondary Failure of Oral Antihyperglycemic Treatment
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2010
Completion date
May 31, 2012
Enrollment
888 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus